Henrik Hallengreen Laustsen

Henrik Hallengreen Laustsen is a seasoned financial professional specializing in equity research, currently serving as a Senior Analyst at Jyske Bank since March 2019. In this role, Henrik focuses on the healthcare and brewery sectors in Denmark, with particular attention to companies such as Novo Nordisk, Coloplast, Genmab, Carlsberg, Royal Unibrew, and Tomra. Responsibilities include developing valuation models and financial analyses to support investment cases for both private and institutional investors. Prior experience encompasses positions as an Analyst at Asset Advisor Fondsmæglerselskab A/S and as an Assisting Analyst in Equities at Jyske Bank, where Henrik engaged in detailed industry analysis and financial assessments. Educational credentials include a Master of Science and Bachelor's Degree in Economics and Management from Aarhus University, complemented by foundational studies at Holstebro Handelsskole.